COMPANY INSIGHT

Sponsored by Capsugel

Lonza Pharma & Biotech – Capsule Delivery Solutions

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally

For more than 100 years, biopharmaceutical companies have relied on the quality, consistency and functional innovations Capsugel® has delivered; today we produces more than 200 billion capsules in over 100 countries.

Building on our history of innovation in polymer science and capsule engineering, Capsule Delivery Solutions continues to launch ground-breaking capsule designs and equipment technologies that are improving drug development and delivery. Whether you’re looking to formulate new products or enhance an existing line, we have the right capsule to help you bring improved products to market faster. With a diverse portfolio including HPMC, Dry Powder Inhalation capsules or specialized clinical capsules, we are a global leader in capsule development and manufacturing, bringing unmatched products and technical support to our worldwide customer base.

Capsule Delivery Solutions Quality  

From the purchase of key raw materials to the manufacturing, packaging and delivering of finished products, Capsule Delivery Solutions works to ensure the safety and quality of capsules we supply to pharmaceutical customers around the world.

As key elements of our quality commitment, Capsugel is investing in Regulatory Compliance Monitoring Programs that anticipates and proactively responds to the continuously evolving global food-safety standards and maintains a robust Quality System, from sourcing of our ingredients to the distribution of our products, that is compliant with all applicable standards.

Capsule Delivery Solutions offers  

High quality empty capsules:

  • Immediate release: Coni-Snap® Gelatin, Vcaps® Plus, Plantcaps®
  • Targeted & Modified release: Vcaps® Enteric, DUOCAP®
  • Dry Powder Inhalation capsules: Gelatin: Coni-Snap® Gelatin and Coni-Snap® Gelatin-PEG, HPMC: Vcaps® and Vcaps® Plus
  • Preclinical and clinical development capsules: PCcaps®, DBcaps®
  • Patient Centric capsules: Coni-Snap® Sprinkle
  • Life Cycle Management solutions: Press-Fit®, XPress-Fit®

Innovative and tailored services:

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI